Zantac Makers, Retailers Urge Nix Of Medical Monitoring Class

By Carolina Bolado ( August 24, 2021, 6:48 PM EDT) -- Manufacturers and retailers of the heartburn medication Zantac urged a Florida federal judge on Monday to dismiss the medical monitoring claims of a class of consumers in multidistrict litigation because they had failed to show that their exposure to the carcinogen in the drug was enough to increase their risk of cancer....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!